Frederikke Lykke-Sørensen, DVM

Nonclinical Development Scientist

Frederikke Lykke-Sørensen, DVM, is a Scientist, Nonclinical Development at Hemab. As a newly graduated veterinarian with a specialization in biomedical sciences, she brings a strong foundation in translational research and drug development. She has four years of hands-on experience as a student assistant at Ascendis Pharma A/S, where she contributed to nonclinical development and bioanalysis projects. This experience provided her with valuable insights into early-stage drug development processes and analytical methodologies. She earned her DVM from the University of Copenhagen.

Meet the Team

Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders

Leadership
Board
Team
Investors
novo holdings
RA Capital
HealthCap
Access Biotechnology
Deep Track Capital
Avoro Ventures
Invus
Rock Springs Capital
Maj Invest Equity
Hemab team photo
Hemab icon in larger circles

We’re building the ultimate clotting company.